| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.BRAINRES.2004.03.018 |
| P698 | PubMed publication ID | 15140644 |
| P2093 | author name string | Donard S Dwyer | |
| Ronald J Bradley | |||
| Xiao-Hong Lu | |||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | phosphorylation | Q242736 |
| P304 | page(s) | 58-68 | |
| P577 | publication date | 2004-06-01 | |
| P1433 | published in | Brain Research | Q4955782 |
| P1476 | title | Olanzapine produces trophic effects in vitro and stimulates phosphorylation of Akt/PKB, ERK1/2, and the mitogen-activated protein kinase p38. | |
| P478 | volume | 1011 |
| Q46441373 | A comparative study of beta-amyloid peptides Abeta1-42 and Abeta25-35 toxicity in organotypic hippocampal slice cultures |
| Q33926752 | Activation of the JAK-STAT pathway by olanzapine is necessary for desensitization of serotonin2A receptor-stimulated phospholipase C signaling in rat frontal cortex but not serotonin2A receptor-stimulated hormone release |
| Q39922746 | Activation of the JAK-STAT pathway is necessary for desensitization of 5-HT2A receptor-stimulated phospholipase C signalling by olanzapine, clozapine and MDL 100907. |
| Q37139258 | Antipsychotic drug mechanisms: links between therapeutic effects, metabolic side effects and the insulin signaling pathway |
| Q42185376 | Antipsychotic drugs activate the C. elegans akt pathway via the DAF-2 insulin/IGF-1 receptor |
| Q40312591 | Antipsychotic drugs cause glial cell line-derived neurotrophic factor secretion from C6 glioma cells. |
| Q40365362 | Antipsychotic drugs inhibit the human corticotropin-releasing-hormone gene promoter activity in neuro-2A cells-an involvement of protein kinases |
| Q30386608 | Antipsychotic drugs: comparison in animal models of efficacy, neurotransmitter regulation, and neuroprotection |
| Q50440426 | Aripiprazole protects cortical neurons from glutamate toxicity |
| Q51246446 | Association of Protein Kinase B (AKT) DNA Hypermethylation with Maintenance Atypical Antipsychotic Treatment in Patients with Bipolar Disorder. |
| Q35852767 | Autophagy inhibition uncovers the neurotoxic action of the antipsychotic drug olanzapine. |
| Q22252332 | Bipolar disorder and mechanisms of action of mood stabilizers |
| Q33764262 | Clozapine acts as an agonist at serotonin 2A receptors to counter MK-801-induced behaviors through a βarrestin2-independent activation of Akt |
| Q54576279 | Clozapine and lithium require Caenorhabditis elegans β-arrestin and serum- and glucocorticoid-inducible kinase to affect Daf-16 (FOXO) localization. |
| Q51102233 | Clozapine as the most efficacious antipsychotic for activating ERK 1/2 kinases: Role of 5-HT2A receptor agonism. |
| Q48881589 | Clozapine induction of ERK1/2 cell signalling via the EGF receptor in mouse prefrontal cortex and striatum is distinct from other antipsychotic drugs |
| Q46092553 | Clozapine-induced ERK1 and ERK2 signaling in prefrontal cortex is mediated by the EGF receptor. |
| Q48441064 | Differential effects of haloperidol and olanzapine on the expression of erythropoietin and its receptor in rat hippocampus and striatum |
| Q34660464 | Docosahexaenoic Acid Suppresses Neuroinflammatory Responses and Induces Heme Oxygenase-1 Expression in BV-2 Microglia: Implications of Antidepressant Effects for Omega-3 Fatty Acids |
| Q38177357 | Drug discovery based on genetic and metabolic findings in schizophrenia |
| Q27693888 | Drug elucidation: invertebrate genetics sheds new light on the molecular targets of CNS drugs |
| Q39851823 | Early effects of mood stabilizers on the Akt/GSK-3beta signaling pathway and on cell survival and proliferation |
| Q34576434 | Effect of chronic exposure to antipsychotic medication on cell numbers in the parietal cortex of macaque monkeys |
| Q54525405 | Effects of aripiprazole and clozapine on the treatment of glycolytic carbon in PC12 cells. |
| Q36687842 | Evidence for neuroprotective effects of antipsychotic drugs: implications for the pathophysiology and treatment of schizophrenia |
| Q38060893 | Improving myelin/oligodendrocyte-related dysfunction: a new mechanism of antipsychotics in the treatment of schizophrenia? |
| Q51802385 | In vitro functional characteristics of dopamine D2 receptor partial agonists in second and third messenger-based assays of cloned human dopamine D2Long receptor signalling. |
| Q39327912 | Interferon-α induces nitric oxide synthase expression and haem oxygenase-1 down-regulation in microglia: implications of cellular mechanism of IFN-α-induced depression |
| Q36248058 | Mechanistic connections between glucose/lipid disturbances and weight gain induced by antipsychotic drugs |
| Q101403037 | N-acetylcysteine prevents olanzapine-induced oxidative stress in mHypoA-59 hypothalamic neurons |
| Q34662630 | Neurogenic actions of atypical antipsychotic drugs and therapeutic implications |
| Q33267049 | Neuroprotection and enhancement of neurite outgrowth with small molecular weight compounds from screens of chemical libraries |
| Q41950823 | Olanzapine Reversed Brain Gene Expression Changes Induced by Phencyclidine Treatment in Non-Human Primates |
| Q40380108 | Olanzapine impairs glycogen synthesis and insulin signaling in L6 skeletal muscle cells. |
| Q48142941 | Olanzapine potentiates neuronal survival and neural stem cell differentiation: regulation of endoplasmic reticulum stress response proteins |
| Q36606052 | Possible mechanisms of neurodegeneration in schizophrenia. |
| Q33238062 | Prototypical antipsychotic drugs protect hippocampal neuronal cultures against cell death induced by growth medium deprivation |
| Q40045402 | Regulation of cyclic AMP response-element binding-protein (CREB) by Gq/11-protein-coupled receptors in human SH-SY5Y neuroblastoma cells |
| Q34993652 | Structure-based discovery of low molecular weight compounds that stimulate neurite outgrowth and substitute for nerve growth factor |
| Q48790631 | The activation of the Akt/PKB signalling pathway in the brains of clozapine-exposed rats is linked to hyperinsulinemia and not a direct drug effect |
| Q38189780 | The emerging role of dopamine-glutamate interaction and of the postsynaptic density in bipolar disorder pathophysiology: Implications for treatment |
| Q33583992 | The neurotrophic and neuroprotective effects of psychotropic agents. |
| Q42176718 | α7 nicotinic ACh receptor-deficient mice exhibit sustained attention impairments that are reversed by β2 nicotinic ACh receptor activation |
Search more.